Omeros Corporation (OMER) Stock: Headed Up On Earnings

Omeros Corporation OMER Stock News

Omeros Corporation (NASDAQ: OMER) is working its way to the top in the pre-market hours this morning after reporting its earnings for the fourth quarter and full 2018 year. Of course, the earnings were positive, exciting investors and pushing the stock up. Today, we’ll talk about: The financial results; what we’re seeing from OMER stock … Read more

Omeros (OMER) Stock: Falling Hard On Offering News

Omeros Corporation (NASDAQ: OMER) is tumbling in the market this morning after the company announced the pricing of an offering. Unfortunately, the pricing showed that the transaction will lead to heavy dilution at a very steep discount. Of course, that news upset investors and sent the stock falling. Today, we’ll talk about: The offering; what … Read more

Omeros Corporation (OMER) Stock: Climbing On Orphan Medicinal Products Designation

Omeros Corporation (NASDAQ: OMER) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that it has received Orphan Medicinal Products designation from the European Commission. Of course, the news excited investors, sending the stock on a run for the top. Today, we’ll talk about: The … Read more

Omeros Corporation (OMER) Stock: Heads For The Top On Financial Results

Omeros Corporation (NASDAQ: OMER) is having an overwhelmingly strong day in the market today, and for good reason. The company reported its financial results for the first quarter, exciting investors and sending the stock screaming for the top. Today, we’ll talk about: What we saw from earnings; what we’re seeing from the stock; and what … Read more

Omeros (OMER) Stock: Gaining Big On Favorable Medicare Spending Bill

Omeros Corporation (NASDAQ: OMER) is having an overwhelmingly strong start to the trading session this morning. However, if you do some digging on Yahoo! Finance or the investor relations website for the company, you’ll see that no news was released that is company specific. Nonetheless, there’s a good reason for the gains today, as American congressional … Read more

Omeros (OMER) Stock: Gaining On Strong Clinical Data

Omeros Corporation (NASDAQ: OMER) is having an overwhelmingly strong day in the market today, and for good reason. The company announced data from a key clinical trial, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the data, what we’re seeing from the stock, and what we’ll be … Read more

Omeros Corporation (OMER) Stock: Skyrockets On Breakthrough Therapy Designation

Omeros Corporation (NASDAQ: OMER) is having an incredibly strong day in today’s trading session and for good reason. The company was just granted breakthrough therapy designation with regard to a key treatment candidate. As a result, investor excitement ensued, leading to gains in the stock and prompting our partners at Trade Ideas to alert us … Read more